The "Subsidy scheme for promising care" will be discontinued in the Netherlands

The so-called “Subsidy for Promising Care” was implemented in 2019 to support the development of missing clinical and economic evidence for promising care, which otherwise cannot be covered within basic health insurance. Evidence developed in the program should support a positive assessment by the Dutch Healthcare Institute (ZIN) in the future and coverage within Basic Health Insurance. The Ministry of Health, Welfare, and Sport allocated about €69 mil annually for the scheme. The scheme was administered by the ZIN and the Dutch Organization for Health Research and Development (ZonMw).

There are currently 28 ongoing projects. The last 2025 rounds of application submissions are closed. The decision on approved projects will be published by the beginning of April 2025 and by September 25, 2025, respectively, for the first and second rounds of the scheme for 2025. A maximum of €39 million will be available for the last projects awarded in 2025.

In October 2024, the Ministry of Health, Welfare, and Sport decided to stop the subsidy scheme. The ZIN is in consultation with the Ministry of Health, Welfare, and Sport to continue stimulating research into the cost-effectiveness of promising care that is not yet reimbursed under the basic health insurance package from public funds. The ZIN will share further details on the website.

See more information in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor weekly from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.